Two phase 3 studies show that Eli Lilly and Company's (NYSE: LLY) ultra rapid lispro (URLi) provided non-inferior A1C reductions compared to Humalog® (insulin lispro) at 26 weeks in people with...

SC Johnson and the United Nations Association of the United States of America (UNA-USA) will host a screening today of the acclaimed film "Love Sonia," the story of a young girl's journey to...

In a comparison of two different diet and two different weight management programs, results of the international PREVIEW intervention study found a low, similar rate of progression to type 2...

Results from several studies of Eli Lilly and Company's (NYSE: LLY) investigational dual GIP and GLP-1 receptor agonist (RA), tirzepatide, reinforce its potential in lowering A1C and body weight...

Brad Keywell, CEO of US-based Uptake Technologies, Inc., was this evening named EY World Entrepreneur Of The Year™ 2019 at an award ceremony held in Monaco's Salle des Etoiles. Brad was selected...